Related Experiment Video

Updated: Nov 18, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.0K

A new predictive biomarker enables more accurate PD-1 blockade therapy

Kuojun Zhang1, Sheng Jiang2

  • 1State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Cellular & Molecular Immunology
|February 9, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

819
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.5K

Related Experiment Videos

Last Updated: Nov 18, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.0K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

819
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K

Articles linked to this work by shared authors, journal, and citation graph.

Gut microbiota as modulators of obesity and overweight: a registry-based systematic review of clinical trial evidence.

Frontiers in nutrition·2026

Dynamic evolution of readmission risk factors across short-, medium-, and long-term horizons in type 2 diabetes: a machine learning-based predictive modeling study with SHAP interpretability.

Frontiers in endocrinology·2026

MRAM: A Versatile Non-Volatile Memory for Next-Generation Computing.

Nanomaterials (Basel, Switzerland)·2026

Reference intervals for venous blood gas measurement in a healthy Chinese population.

Clinica chimica acta; international journal of clinical chemistry·2026

Exosomal miRNA-714 derived from adipose tissue macrophages regulates adipocyte glucose and lipid metabolism via IGF1R targeting.

Nutrition & metabolism·2026

The correlation between the atherogenic index of plasma and aortic valve calcification in the general population: a retrospective observational cohort study.

Frontiers in endocrinology·2026

IL-17D reprograms CD93+ antigen-presenting cells in the glioblastoma microenvironment.

Cellular & molecular immunology·2026

Radiation-induced CD200+ tumor-associated macrophages suppress eosinophil-mediated antitumor immunity through CD200R signaling in hepatocellular carcinoma.

Cellular & molecular immunology·2026

MARCH2/3 target FcγRI for K27-linked polyubiquitination and degradation to restrict the inflammatory response.

Cellular & molecular immunology·2026

Platelet-derived serotonin epigenetically programs macrophage alternative activation to orchestrate type 2 airway inflammation.

Cellular & molecular immunology·2026

NLRC3 enhances antitumor immunity by specifically negatively regulating M-MDSCs in a STING-dependent manner.

Cellular & molecular immunology·2026

Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a.

Cellular & molecular immunology·2026

PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.

Neuro-oncology·2026

Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care.

The Journal of clinical endocrinology and metabolism·2026

Advances in Formulation and Technological Strategies for Montelukast Pulmonary Delivery.

ACS omega·2026

Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy.

ACS omega·2026

Exosomes in brain diseases: Mechanisms, advances, and perspectives.

Bioactive materials·2026

Quantification of Ocular Gene Therapy-Related Inflammation Using the VRMACS Grading System.

Ophthalmology science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us